Pyrithione-based ruthenium complexes as inhibitors of aldo-keto reductase 1C enzymes and anticancer agents.

about

Aldo-Keto Reductase AKR1C1-AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy.AKR1C enzymes sustain therapy resistance in paediatric T-ALL.

P2860

Q37698258-3D29EB6B-0155-4DD3-B283-91EFE35A0FF3 Q53703893-CCC758E1-847D-492A-A291-D4D4AF14000C

P2860

Pyrithione-based ruthenium complexes as inhibitors of aldo-keto reductase 1C enzymes and anticancer agents.

Item

http://www.wikidata.org/entity/Q38760811

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Pyrithione-based ruthenium com ...... enzymes and anticancer agents.

@en

type

Item

label

Pyrithione-based ruthenium com ...... enzymes and anticancer agents.

@en

prefLabel

Pyrithione-based ruthenium com ...... enzymes and anticancer agents.

@en

P1476

Pyrithione-based ruthenium com ...... enzymes and anticancer agents.

@en

P2093

Elisa Esteve Codina

http://www.w3.org/2001/XMLSchema#string

Iztok Turel

http://www.w3.org/2001/XMLSchema#string

Jakob Kljun

http://www.w3.org/2001/XMLSchema#string

Jure Stojan

http://www.w3.org/2001/XMLSchema#string

Katja Traven

http://www.w3.org/2001/XMLSchema#string

Maja Anko

http://www.w3.org/2001/XMLSchema#string

Maša Sinreih

http://www.w3.org/2001/XMLSchema#string

Renata Pavlič

http://www.w3.org/2001/XMLSchema#string

Tea Lanišnik Rižner

http://www.w3.org/2001/XMLSchema#string

Špela Peršič

http://www.w3.org/2001/XMLSchema#string

P2860

Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer

Mechanism of the antimicrobial action of pyrithione: effects on membrane transport, ATP levels, and protein synthesis

Activity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer c

Preparation of a cross-linked porous protein crystal containing Ru carbonyl complexes as a CO-releasing extracellular scaffold

Cisplatin binding to human serum albumin: a structural study

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs.

Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells.

In vivo evaluation of small-molecule thermoresponsive anticancer drugs potentiated by hyperthermia.

Exploring the influence of the protein environment on metal-binding pharmacophores.

P304

11791-11800

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C6DT00668J

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27357845

http://www.w3.org/2001/XMLSchema#string

Pyrithione-based ruthenium complexes as inhibitors of aldo-keto reductase 1C enzymes and anticancer agents.

about

P2860

P2860

Pyrithione-based ruthenium complexes as inhibitors of aldo-keto reductase 1C enzymes and anticancer agents.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698